Navigation Links
Neurobiological Technologies Announces Intent to File Form 25 to Delist Common Stock From the NASDAQ Capital Market
Date:10/19/2009

EMERYVILLE, Calif., Oct. 19 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (Nasdaq: NTII) ("NTI") announced today it has submitted written notice to the NASDAQ Stock Market LLC ("NASDAQ") that NTI intends to file a Form 25 with the Securities and Exchange Commission ("SEC") on or about October 28, 2009 to effect the voluntary delisting of its common stock from NASDAQ, if NTI's stockholders approve the dissolution of the company pursuant to a Plan of Complete Liquidation and Dissolution at the special meeting of stockholders planned for Tuesday, October 27, 2009.

Details of NTI's plans to pay an extraordinary dividend, delist its common stock from the Nasdaq Capital Market, discontinue recording transfers of stock, cease its reporting obligations under the Securities Exchange Act of 1934, as amended, and distribute its net cash to stockholders can be found in a definitive proxy statement filed with the SEC on September 22, 2009.

About Neurobiological Technologies, Inc.

Neurobiological Technologies, Inc. is a biopharmaceutical company historically focused on developing investigational drugs for central nervous system conditions.

SOURCE Neurobiological Technologies, Inc.


'/>"/>
SOURCE Neurobiological Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Neurobiological Technologies Receives Nasdaq Closing Bid Price Notification
2. Neurobiological Technologies Announces Termination of its License and Cooperation Agreement with Merz and Childrens Medical Center
3. Neurobiological Technologies Announces Hiring of Advisor to Seek Sale of Company
4. Neurobiological Technologies Reports Second Quarter Fiscal 2009 Financial Results
5. Neurobiological Technologies Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of Memantine
6. Neurobiological Technologies Announces Suspension of Viprinex Development
7. Neurobiological Technologies Partner, Celtic Pharma, Provides Update on XERECEPT(R) Clinical Program and Planned Sale in 2009
8. Neurobiological Technologies, Inc. Reports First Quarter Fiscal Year 2009 Financial Results
9. Neurobiological Technologies to Present at the Rodman & Renshaw 10th Annual Healthcare Conference in New York on November 10
10. Neurobiological Technologies Sets Date for First Quarter Financial Results
11. Neurobiological Technologies Reports Receipt of $2 Million Royalty Payment for Quarterly Sales of Memantine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 1, 2014  Spherix Incorporated (Nasdaq: SPEX) -- an intellectual ... monetization of intellectual property, announced today that the ... Uniden in the U.S. District Court for the ... has been rescheduled for November 10, 2014.  This ... The Court Order setting the Markman date was ...
(Date:10/1/2014)... Irvine, CA (PRWEB) September 30, 2014 ... for user-friendly, cost-effective tools to address sales, training ... PMG has developed innovative mobile applications to ... studies, outlining the agency’s latest customized mobile app ... http://www.studiopmg.com/work . , In partnership with Toyota, ...
(Date:10/1/2014)... Ill. (PRWEB) October 01, 2014 The ... $9,956,011 to Southern Illinois University Edwardsville as part of ... (TAACCCT) initiative. The funding is co-administered by the Department ... Joe Biden, Secretary of Labor Thomas E. Perez and ... $450 million in job-driven training grants to nearly 270 ...
(Date:9/30/2014)... This news release is available in German . ... at the Technische Universitt Mnchen (TUM) have demonstrated a ... Their experiments show that future computer chips could be ... transistors. As the main enabling technology of the semiconductor ... fundamental limits, the TUM researchers and collaborators at the ...
Breaking Biology Technology:Markman Hearing Date for VTech and Uniden Litigation Now Set for November 10, 2014 2Digital Agency Studio PMG Launches New Case Studies on Website 2U.S. Dept. of Labor Awards SIUE Nearly $10-Million Grant 2U.S. Dept. of Labor Awards SIUE Nearly $10-Million Grant 3U.S. Dept. of Labor Awards SIUE Nearly $10-Million Grant 4A new dimension for integrated circuits: 3-D nanomagnetic logic 2A new dimension for integrated circuits: 3-D nanomagnetic logic 3
... ... ... , , , ... ...
... ... web to cost effectively boost the pool of eligible patients for screening for any ... upload recruitment material approved by their Institutional Review Board (IRB), on their own specific ... ...
... ... ... ... ...
Cached Biology Technology:Spectral granted IDE approval by U.S. FDA to conduct pivotal trial for Toraymyxin(TM) 2Spectral granted IDE approval by U.S. FDA to conduct pivotal trial for Toraymyxin(TM) 3Spectral granted IDE approval by U.S. FDA to conduct pivotal trial for Toraymyxin(TM) 4RESolutions Rapid Enrollment Solutions, LLC Announces Launch of Novel Patient Recruitment Web Site - Clinical Trial Spotlight™ 2RESolutions Rapid Enrollment Solutions, LLC Announces Launch of Novel Patient Recruitment Web Site - Clinical Trial Spotlight™ 3China-Biotics, Inc. Inaugurated the Commercial Production of its New Production Facility 2China-Biotics, Inc. Inaugurated the Commercial Production of its New Production Facility 3China-Biotics, Inc. Inaugurated the Commercial Production of its New Production Facility 4China-Biotics, Inc. Inaugurated the Commercial Production of its New Production Facility 5China-Biotics, Inc. Inaugurated the Commercial Production of its New Production Facility 6China-Biotics, Inc. Inaugurated the Commercial Production of its New Production Facility 7
(Date:9/30/2014)... DURHAM, N.C. -- Pollution in urban and farm runoff ... a new study finds. , The study, published ... shows that nitrogen in the runoff ends up in ... tumors on the animals, eyes, flippers and internal organs. ... and the National Oceanic and Atmospheric Administration (NOAA) conducted ...
(Date:9/30/2014)... wrong with your muscles because of age, disease or injury, ... That,s where a new research report published in the October ... comes in. In the report, a team of scientists produce ... scientists "see" which genes are active in an organ at ... and that men have approximately 400 more active genes in ...
(Date:9/30/2014)... , Sept. 30, 2014  Spectra ... solutions for the biotech and power generation ... new RECONN Bioprocess Manager, an easy-to-use and ... geared towards bioprocess development laboratories. ... disparate bioreactor and analyzer systems. Accessing and ...
Breaking Biology News(10 mins):Pollution linked to lethal sea turtle tumors 2Pollution linked to lethal sea turtle tumors 3Scientists identify which genes are active in muscles of men and women 2Spectra Automation Introduces RECONN Bioprocess Manager 2
... National Institute of Standards and Technology (NIST) have ... clumps of proteins in protein-based pharmaceuticals. This first ... can be assured that their instruments are faithfully ... concern because of its impact on quality control ...
... laundry products and air fresheners found the products emitted ... off at least one chemical regulated as toxic or ... was listed on the product labels. , "I first ... me that the air fresheners in public restrooms and ...
... the first issue of , Energy & Environmental Science ... Free for all to read online, this inaugural ... hydrogen storage, thermochemical biofuel production, sustainable energy, and much ... of the highest quality, knowing that they can rely ...
Cached Biology News:NIST trumps the clumps: Making biologic drugs safer 2Toxic chemicals found in common scented laundry products, air fresheners 2Toxic chemicals found in common scented laundry products, air fresheners 3